Atossa Therapeutics Inc (ATOS)
1.535
+0.06
(+3.72%)
USD |
NASDAQ |
Apr 24, 15:28
Atossa Therapeutics Cash from Investing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | -0.001M |
| June 30, 2023 | -0.013M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -2.008M |
| September 30, 2022 | -2.706M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.013M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.009M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.0004M |
| September 30, 2020 | -0.0028M |
| June 30, 2020 | -0.0066M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -0.0076M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0565M |
| September 30, 2018 | -0.003M |
| June 30, 2018 | -0.0004M |
| March 31, 2018 | -0.0511M |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -0.0042M |
| September 30, 2016 | -0.0001M |
| June 30, 2016 | 0.0001M |
| March 31, 2016 | -0.005M |
| December 31, 2015 | -0.1777M |
| September 30, 2015 | -0.0291M |
| June 30, 2015 | -0.0156M |
| March 31, 2015 | -0.066M |
| December 31, 2014 | -0.0557M |
| September 30, 2014 | -0.0964M |
| June 30, 2014 | -0.0881M |
| March 31, 2014 | -0.103M |
| December 31, 2013 | -0.0891M |
| September 30, 2013 | -0.3108M |
| June 30, 2013 | -0.0814M |
| March 31, 2013 | -0.0085M |
| December 31, 2012 | -0.1346M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | -0.0517M |
| September 30, 2011 | -0.0156M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-2.706M
Minimum
Sep 2022
0.0004M
Maximum
Dec 2020
-0.2509M
Average
--
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| AngioDynamics Inc | 29.40M |
| Biolase Inc | -0.003M |
| Outset Medical Inc | 23.42M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.571M |
| Free Cash Flow | -20.96M |
| Free Cash Flow Per Share (Quarterly) | -0.0445 |
| Free Cash Flow Yield | -10.83% |